These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23464798)

  • 1. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid.
    Goldberg D; Guana A; Volk A; Daro-Kaftan E
    Dermatol Surg; 2013 Jun; 39(6):915-22. PubMed ID: 23464798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles.
    Brandt FS; Cazzaniga A; Baumann L; Fagien S; Glazer S; Kenkel JM; Lowe NJ; Monheit GD; Narins RS; Rendon MI; Rohrich RJ; Werschler WP
    Aesthet Surg J; 2011 Jul; 31(5):521-8. PubMed ID: 21719865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles.
    Narins RS; Baumann L; Brandt FS; Fagien S; Glazer S; Lowe NJ; Monheit GD; Rendon MI; Rohrich RJ; Werschler WP
    J Am Acad Dermatol; 2010 Mar; 62(3):448-62. PubMed ID: 20159311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subject global evaluation and subject satisfaction using injectable poly-L-lactic acid versus human collagen for the correction of nasolabial fold wrinkles.
    Brown SA; Rohrich RJ; Baumann L; Brandt FS; Fagien S; Glazer S; Kenkel JM; Lowe NJ; Monheit GD; Narins RS; Rendon MI; Werschler WP
    Plast Reconstr Surg; 2011 Apr; 127(4):1684-1692. PubMed ID: 21460676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biological basis for poly-L-lactic acid-induced augmentation.
    Stein P; Vitavska O; Kind P; Hoppe W; Wieczorek H; Schürer NY
    J Dermatol Sci; 2015 Apr; 78(1):26-33. PubMed ID: 25703057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retreatment with injectable poly-l-lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific study.
    Mest DR; Humble GM
    Dermatol Surg; 2009 Feb; 35 Suppl 1():350-9. PubMed ID: 19207325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy.
    Moyle GJ; Brown S; Lysakova L; Barton SE
    HIV Med; 2006 Apr; 7(3):181-5. PubMed ID: 16494632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional digital surface imaging measurement of the volumizing effect of injectable poly-L-lactic acid for nasolabial folds.
    Lowe P; Lowe NJ; Patnaik R
    J Cosmet Laser Ther; 2011 Apr; 13(2):87-94. PubMed ID: 21401382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for restoration of soft tissue volume.
    Schierle CF; Casas LA
    Aesthet Surg J; 2011 Jan; 31(1):95-109. PubMed ID: 21239677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES).
    Bassichis B; Blick G; Conant M; Condoluci D; Echavez M; Eviatar J; Gold MH; Hamilton T; Hanke CW; Humble G; LaMarca A; Daro-Kaftan E; Mest D; Pierone G
    Dermatol Surg; 2012 Jul; 38(7 Pt 2):1193-205. PubMed ID: 22759256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition and mechanism of action of poly-L-lactic acid in soft tissue augmentation.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s29-31. PubMed ID: 24719074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable poly-L: -lactic acid: a novel sculpting agent for the treatment of dermal fat atrophy after severe acne.
    Sadove R
    Aesthetic Plast Surg; 2009 Jan; 33(1):113-6. PubMed ID: 18923863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Canadian study of the use of poly-L-lactic acid dermal implant for the treatment of hill and valley acne scarring.
    Sapra S; Stewart JA; Mraud K; Schupp R
    Dermatol Surg; 2015 May; 41(5):587-94. PubMed ID: 25915626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly-L-lactic acid: a new dimension in soft tissue augmentation.
    Rotunda AM; Narins RS
    Dermatol Ther; 2006; 19(3):151-8. PubMed ID: 16784514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of correction for human immunodeficiency virus-associated lipoatrophy after retreatment with injectable poly-L-lactic acid.
    Mest DR; Humble GM
    Aesthetic Plast Surg; 2009 Jul; 33(4):654-6. PubMed ID: 18704558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cosmetic use of poly-l-lactic acid: a retrospective study of 130 patients.
    Palm MD; Woodhall KE; Butterwick KJ; Goldman MP
    Dermatol Surg; 2010 Feb; 36(2):161-70. PubMed ID: 20039924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of injectable poly-L-lactic acid from the correction of HIV-related facial lipoatrophy to aging-related facial contour deficiencies.
    Burgess C
    J Drugs Dermatol; 2011 Sep; 10(9):1001-6. PubMed ID: 22052268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly-L-lactic acid.
    Perry CM
    Am J Clin Dermatol; 2004; 5(5):361-6; discussion 367-8. PubMed ID: 15554738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of injection with poly-L-lactic acid compared with hyaluronic acid for correction of nasolabial fold: a randomized, evaluator-blinded, comparative study.
    Hyun MY; Lee Y; No YA; Yoo KH; Kim MN; Hong CK; Chang SE; Won CH; Kim BJ
    Clin Exp Dermatol; 2015 Mar; 40(2):129-35. PubMed ID: 25319932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimizing adverse events associated with poly-L-lactic acid injection.
    Narins RS
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S100-4. PubMed ID: 18547172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.